AAM listened to our members and conference attendees and has created the ultimate event for the industry. We combined all our conferences — with the exception of the annual meeting — into the single best opportunity to hear directly from government officials, learn best practices and connect with peers in the generics and biosimilars industry.
GRx+Biosims is the name of the combined event that replaces FallTech, Leading on Biosimilars and CMC Workshop. The program will be comprehensive and the speakers are the top in their field. Whatever your interests, you will find what you need at GRx+Biosims. With science, policy and the market in constant flux, it is critical to come together as an industry to “engineer the future of generic and biosimilar medicines.”
View our meeting registration fees.
Be part of the GRx+Biosims 2018 Exposition.
Inquire about our sponsorship opportunities.
Follow the event on Twitter: #GRxBiosms
401 W Pratt St.
Baltimore, MD 21201
Reservations must be made directly with the Hilton Baltimore by calling 1-800-445-8667 or online by clicking here. Please refer to the SRIP code “ATC” or “GRx+Biosims” to obtain the preferred rate. Only a limited number of preferred rate rooms are available. The preferred rate cut off date is August 8, 2018. After this date or after the preferred rate rooms are sold out, rooms are subject to hotel rates and availability.
About the Biosimilars Council
The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), works to ensure a positive environment for patient access to biosimilar medicines. The Biosimilars Council is a leading source for information about the safety and efficacy of more affordable alternatives to costly brand biologic medicines. Areas of focus include public and health expert education, strategic partnerships, government affairs, legal affairs and regulatory policy. More information is available on our about page.
AAM is driven by the belief that access to safe, quality, effective medicine has a tremendous impact on a person’s life and the world around them. Generic and biosimilar medicines improve people’s lives, improving society and the economy in turn. AAM represents the manufacturers and distributors of finished generic pharmaceuticals and biosimilars, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals are 90 percent of prescriptions dispensed in the U.S. but only 23 percent of total drug spending. Additional information is available at www.accesiblemeds.org.